Skip to main content



) --

Momenta Pharmaceuticals



) is trading at unusually high volume Thursday with 3.6 million shares changing hands. It is currently at four times its average daily volume and trading up 31 cents (+2.9%) at $10.93 as of three p.m. ET.

Momenta has a market cap of $593.6 million and is part of the

health care

sector and


industry. Shares are down 29.1% year to date as of the close of trading on Wednesday.

Momenta Pharmaceuticals, Inc., a biotechnology company, specializes in the in the characterization and process engineering of complex molecules. These complex molecules include proteins; polypeptides; and cell surface polysaccharides, such as heparan-sulfate proteoglycans (HSPGs). The company has a P/E ratio of three, equal to the average drugs industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Momenta as a


. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. You can view the full

Momenta Ratings Report


See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center


Interested in other stocks that are rising on unusually high volume? Get free SMS text alerts sent to you when the action happens by texting


to 95370 or select from

multiple alert options